Your session is about to expire
Norvasc vs Cozaar
Introduction
For patients with hypertension or other cardiovascular conditions, certain drugs that help to regulate blood pressure and maintain heart health can be critical. Norvasc and Cozaar are two such medications often prescribed for these conditions. Both have different mechanisms of action but contribute towards the overall goal of managing high blood pressure and decreasing the risk of associated complications. Norvasc is a calcium channel blocker (CCB), affecting the movement of calcium into cells within the heart and blood vessels, which helps to relax those vessels. Cozaar, on the other hand, is classified as an angiotensin II receptor antagonist (ARB). It works by blocking a substance in the body called angiotensin II from binding to receptors on blood vessels, resulting in relaxation and dilation of these vessels.
Norvasc vs Cozaar Side By Side
| Attribute | Norvasc | Cozaar |
|---|---|---|
| Brand Name | Norvasc | Cozaar |
| Contraindications | Should not be taken with potassium supplements or salt substitutes containing potassium without consulting a doctor. | Should not be taken with potassium supplements or salt substitutes containing potassium without consulting a doctor. |
| Cost | Brand: ~$450 for 90 tablets (5 mg), Generic: ~$0.10 to $0.50 per day | Brand: ~$170 for 30 tablets (50 mg), Generic: ~$0.20 to $1 per day |
| Generic Name | Amlodipine | Losartan |
| Most Serious Side Effect | New or worsening chest pain, high potassium levels leading to nausea, slow or unusual heart rate, weakness. | Symptoms related to high potassium levels in the blood such as muscle weakness and irregular heartbeats, severe gastrointestinal issues. |
| Severe Drug Interactions | Not specified in the article, but generally, calcium channel blockers can interact with certain heart medications and grapefruit juice. | Not specified in the article, but ARBs can interact with NSAIDs, potassium supplements, and certain diuretics. |
| Typical Dose | 2.5–10 mg/day, with 5 mg/day being adequate for most adults and children over six. | Starts at 50 mg/day, can be increased up to 100 mg/day depending on the patient's response. |
What is Norvasc?
Amlodipine (the generic name for Norvasc) is a calcium channel blocker that was first approved by the FDA in 1987. It works by relaxing blood vessels, allowing blood to flow more easily and lowering blood pressure. By reducing high blood pressure, it can be prescribed for the prevention of strokes, heart attacks, and kidney problems. Amlodipine has a selective influence on vascular smooth muscle cells with only minor effects on cardiac muscle cells.
On the other hand, Losartan (the generic name for Cozaar) belongs to the angiotensin II receptor antagonist class of drugs and works differently from Norvasc. Approved by the FDA in 1995, Losartan prevents tight constriction of muscles surrounding the arteries by blocking angiotensin II receptors; thus resulting in expanded or dilated blood vessels which subsequently lower overall blood pressure levels. While both medications are used to control hypertension effectively, different patients may respond better to one medication over another due to individual health circumstances.
What conditions is Norvasc approved to treat?
Norvasc is approved for the treatment of various cardiovascular conditions:
- Hypertension, also known as high blood pressure
- Coronary artery disease (specifically variant angina and vasospastic angina)
- Chronic stable angina (either alone or in combination with other drugs)
How does Norvasc help with these illnesses?
Norvasc, or amlodipine besylate, assists in managing high blood pressure by relaxing the walls of the blood vessels. This is accomplished by blocking calcium channels on the smooth muscle cells lining the arteries. By inhibiting these calcium channels from opening, less calcium enters these cells leading to relaxation of muscle and dilation of the artery. When arteries are wider, blood can flow more easily through them which reduces overall pressure within them - thus reducing hypertension. Blood vessels play an important role in circulation throughout our body and maintaining their proper functioning is essential to health.
On the other hand, Cozaar or losartan acts similarly in lowering high blood pressure but does so by blocking angiotensin II receptors that cause vasoconstriction (narrowing) of blood vessels and release aldosterone which leads to water retention both contributing towards increased blood pressure. Therefore, by preventing this action patients taking Losartan will experience lower levels of hypertension aiding in overall cardiovascular health.
What is Cozaar?
Cozaar, known generically as losartan, is an angiotensin II receptor antagonist. This means it works by blocking the action of a natural substance called angiotensin II that can tighten blood vessels and thus cause high blood pressure. By relaxing these vessels, Cozaar allows for easier blood flow and lowers overall blood pressure. Losartan was first approved by the FDA in 1995. Unlike Norvasc (a calcium channel blocker), which relaxes the muscles lining your arteries to lower blood pressure, Cozaar acts directly on one of the primary systems regulating this process: the renin-angiotensin system. Its unique mode of action means that its side-effect profile differs from that of other hypertension medications like Norvasc; it causes less swelling or flushing but may lead to dizziness or upper respiratory infection in some patients. The effect on angiotensin can be beneficial for managing high blood pressure, especially in patients who have not responded well to typical calcium channel blockers such as Norvasc.
What conditions is Cozaar approved to treat?
Cozaar, known generically as losartan, is approved for the treatment of:
- Hypertension (high blood pressure) in adults and children who are at least 6 years old.
- Diabetic nephropathy (kidney disease caused by diabetes) in patients with type 2 diabetes who also have high blood pressure. It's important to note that Cozaar can reduce the risk of stroke in people with heart disease.
How does Cozaar help with these illnesses?
Angiotensin II is a potent vasoconstrictor, which means it narrows blood vessels and thus raises blood pressure. It also stimulates the release of another hormone that promotes sodium and water retention in the body—again contributing to increased blood pressure. Cozaar works by blocking angiotensin receptors, thereby preventing the actions of angiotensin II. This results in vessel dilation (widening), reduced secretion and effects of aldosterone, and consequently lower blood pressure. Its action on these biochemical pathways makes Cozaar an effective antihypertensive drug suitable for many patients with high blood pressure or heart failure symptoms. Since it does not significantly affect calcium channels like Norvasc does, it may be prescribed when a patient experiences side effects from "typical" calcium channel blockers or may be combined with such medications for a more comprehensive treatment plan.
How effective are both Norvasc and Cozaar?
Both amlodipine (Norvasc) and losartan (Cozaar) have solid histories of success in treating patients with hypertension, and their approvals by the FDA were only a few years apart. Since they act on different aspects of the cardiovascular system — Norvasc being a calcium channel blocker, and Cozaar an angiotensin II receptor antagonist— they may be prescribed under different circumstances. The effectiveness of Norvasc and Cozaar in alleviating hypertension was directly studied in multiple clinical trials; both drugs showed similar efficacy in managing symptoms of high blood pressure as well as encouraging safety profiles.
A 2003 review demonstrated that Norvasc is effective at reducing blood pressure levels from the first week of treatment, that its side effect profile is favourable compared to many other antihypertensive medications, and that it is well-tolerated even in elderly populations. The same study reports that Norvasc has become one of the most widely-prescribed antihypertensive drug worldwide.
On the other hand, a 2010 review indicated that Cozaar seems to be more effective than placebo in treating hypertension, showing comparable efficacy to other common antihypertensive medications. However, there are situations where Cozaar might be considered before or concurrently with other treatments such as when patients also show signs of heart failure or diabetic nephropathy due to its renoprotective properties. Despite this unique advantage for certain patient groups needing additional kidney protection beyond blood pressure control alone, data confirming its superiority over calcium channel blockers like Amlodipine as standalone hypertensive treatment isn't robust enough yet.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Norvasc typically prescribed?
Oral dosages of Norvasc range from 2.5–10 mg/day, but clinical studies have shown that a daily dose of 5 mg is adequate for managing high blood pressure in most adults and children aged over six years old. For elderly patients or those with liver problems, treatment should begin at a lower dosage (2.5 mg/day). Dosage can be increased after a few weeks if the initial response is inadequate. The maximum recommended dosage not to be exceeded in any case is 10mg per day.
At what dose is Cozaar typically prescribed?
Cozaar treatment commonly starts at a dosage of 50 mg/day. Depending on the patient's response to the medication, the dose can be increased up to 100 mg/day, ideally taken as a single daily dose. However, it may also be split into two doses spaced out over the day if advised by your healthcare provider. If there is no satisfactory reduction in blood pressure or improvement in kidney function after three weeks, your doctor might decide to increase your dosage or add another medicine for better results. As always with any medications, follow your medical professional's instructions diligently and do not exceed prescribed dosages without consultation.
What are the most common side effects for Norvasc?
Common side effects of Norvasc (Amlodipine) may include:
- Swelling ankles/feet (oedema)
- Dizziness
- Lightheadedness
- Flushing
- Tiredness and fatigue
- Nausea, abdominal pain, dyspepsia
- Palpitations (heart pounding)
On the other hand, Cozaar (Losartan) has its own set of common side effects which may include:
- Back pain or leg/knee pain
- Diarrhea
- Dizziness and lightheadedness due to a drop in blood pressure
- Fatigue/tiredness
- Nasal congestion, sinus disorders or upper respiratory infections.
Each person's reaction to these medications can be different so it is important to consult with healthcare providers for personalized information.
Are there any potential serious side effects for Norvasc?
Serious side effects from Norvasc and Cozaar are not common, but in rare instances, they can occur. If you experience any of the following symptoms while taking either medication, seek medical attention immediately:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling of your face, lips, tongue or throat.
- Rapid weight gain or swelling in your hands, ankles or feet.
- New or worsening chest pain.
- Changes in urination patterns - no urinating at all, painful urination.
- High potassium levels leading to nausea, slow or unusual heart rate, weakness or feeling like you might pass out. For Cozaar specifically:
- Light-headedness that leads to fainting spells could be indicative of a sudden drop in blood pressure.
Although these medicines are generally well-tolerated with minimal side effects when prescribed by a doctor and taken correctly under their supervision it's crucial to monitor for these symptoms.
What are the most common side effects for Cozaar?
Potential side effects of Cozaar include:
- Dizziness or lightheadedness due to a drop in blood pressure
- Stuffy nose, sore throat, and upper respiratory infections
- Back pain
- Diarrhea
- Fatigue
- High potassium levels – this could lead to muscle weakness, slow heart rate and a weak pulse.
Remember that each individual may experience side effects differently and it's important to consult with your healthcare provider if you're experiencing any unusual symptoms while taking Cozaar.
Are there any potential serious side effects for Cozaar?
Cozaar, like any other medication, may cause side effects in some individuals. Though it's generally well tolerated, there are a few severe symptoms to watch for:
- Signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue or throat
- A change in the amount of urine produced or difficulty passing urine
- Symptoms related to high potassium levels in the blood such as muscle weakness and irregular heartbeats
- Severe gastrointestinal issues including stomach pain and persistent vomiting
- Changes in vision or eye pain which could indicate a serious condition called Acute Myopia and Secondary Angle-Closure Glaucoma.
If you experience any of these symptoms after taking Cozaar, seek immediate medical attention.
Contraindications for Norvasc and Cozaar?
Both Norvasc and Cozaar, along with most other hypertension medications, may potentially exacerbate certain cardiovascular symptoms in some individuals. If you notice your blood pressure rising or experience severe side effects such as dizziness, fainting spells or a rapid heart rate after starting these medications, please seek immediate medical attention.
Neither Norvasc nor Cozaar should be taken if you are taking, or have been taking potassium supplements or salt substitutes containing potassium without consulting your doctor due to the risk of elevated potassium levels in the body which could result in serious health issues. Always inform your physician about all the medications and dietary supplements you are currently using; substances high in potassium will require careful monitoring during treatment with either Norvasc or Cozaar for safe use.
How much do Norvasc and Cozaar cost?
For the brand name versions of these drugs:
- The price for 90 tablets of Norvasc (5 mg) averages around $450, which works out to about $5/day.
- The price for 30 tablets of Cozaar (50 mg) is typically around $170, working out to approximately $5.70/day.
Thus, if you are using a standard dosage range for either drug, then brand-name Norvasc tends to be slightly less expensive on a per-day treatment basis. However, it's important to remember that cost should not be your primary consideration when determining which medication is right for you.
Regarding the generic versions:
- Amlodipine besylate (the active ingredient in Norvasc), comes in packs ranging from 30 up to 90 tablets with approximate costs varying between $0.10 and $0.50 per day depending on dosages and pack size.
- Losartan potassium (the active ingredient in Cozaar), is also available in packs ranging from 30 up to 90 tablets with prices fluctuating between approximately $0.20 and $1 per day based on dosage and pack size.
These figures demonstrate that both medications can be considerably more affordable when bought as generics rather than under their respective brand names.
Popularity of Norvasc and Cozaar
Amlodipine, in generic form as well as under the brand name Norvasc, was estimated to have been prescribed to about 75 million people in the US in 2020. Amlodipine accounted for just over 9% of antihypertensive prescriptions in the US. However, it appears to be one of the most commonly prescribed calcium channel blockers (not classified with other broad classes of antihypertensives such as ACE inhibitors or beta-blockers). The prevalence of amlodipine has been generally increasing since its introduction.
Losartan, including brand versions such as Cozaar, was prescribed to an estimated 37 million people in the USA in 2020. In terms of usage within its class, losartan accounts for approximately half of all angiotensin receptor blocker (ARB) prescriptions and about 5% overall among antihypertensive medications. The prevalence and use rate of losartan has remained relatively stable over recent years.
Conclusion
Both Norvasc (amlodipine) and Cozaar (losartan) are medications used to manage hypertension, backed by extensive clinical studies illustrating their efficacy in comparison to placebo treatments. In some instances, these two drugs may be combined for a more effective control of blood pressure. However, this approach requires meticulous supervision from a healthcare provider due to potential drug interactions.
The mechanisms of action differ between the two; Norvasc is a calcium channel blocker that relaxes blood vessels allowing easier blood flow, while Cozaar belongs to the category called angiotensin II receptor blockers (ARBs), which work by blocking substances that constrict blood vessels.
Norvasc is often chosen as part of initial treatment regimens for high blood pressure. Still, Cozaar can also serve as first-line therapy or an adjunctive treatment—particularly in patients with diabetic nephropathy or those who have experienced intolerable side-effects from ACE inhibitors.
Both medications are available in generic form offering significant cost savings, especially important for those paying out-of-pocket. The onset of hypotensive effects might not be immediate so both may require some time before full therapeutic benefits become noticeable.
Side-effect profiles vary slightly: dizziness and edema are more prevalent with Norvasc use while upper respiratory infection symptoms seem common with Cozaar. Both drugs are generally well-tolerated but patients should monitor how they feel closely when starting treatment and seek medical attention if any adverse reactions occur.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Moen, M. D., & Wagstaff, A. J. (2005). Losartan. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200565180-00012
- KIM, S., KIM, Y., LIM, D., YOON, M., AHN, Y., ON, Y., … KIM, J. (2007, September). Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in korean adults with mild to moderate hypertension. Clinical Therapeutics. Elsevier BV.http://doi.org/10.1016/j.clinthera.2007.09.018